Pro Adrenomedullin | List of Frontiers open access articles

Original Research

Published on 06 Oct 2022

Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist

in Molecular Innate Immunity

Maram Bawazir
Aetas Amponnawarat
Yvonne Hui
Carole A. Oskeritzian
Hydar Ali

Frontiers in Immunology

doi 10.3389/fimmu.2022.1033794

15,965 views
40 citations

Original Research

Published on 21 Jan 2022

Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The “PINK-CO” Observational Study

in Intensive Care Medicine and Anesthesiology

Luigi Vetrugno
Alessia Sala
Daniele Orso
Francesco Meroi
Sebastiano Fabbro
Enrico Boero
Francesca Valent
Gianmaria Cammarota
Stefano Restaino
Giuseppe Vizzielli

Frontiers in Medicine

doi 10.3389/fmed.2021.768261

3,812 views
19 citations

Original Research

Published on 18 Oct 2024

Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination in vulnerable groups: monitoring cardiovascular safety of COVID-19 vaccination

in General Cardiovascular Medicine

Samipa Pudasaini
Ngoc Han Le
Dörte Huscher
Fabian Holert
David Hillus
Pinkus Tober-Lau
Florian Kurth
Leif Erik Sander
Martin Möckel

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1435038

2,632 views
1 citation

Original Research

Accepted on 26 Feb 2026

Regulation of MRGPRX2-mediated Mast Cell Function by Competence-stimulating Peptide 1 (CSP-1) and Pro-adrenomedullin Peptide (PAMP-12)

in Molecular Innate Immunity

Aetas Amponnawarat
SANGITA SUTRADHAR
Chalatip Chompunud Na Ayudhya
Maram Bawazir
Ronit Sagi-Eisenberg
Hydar Ali

Frontiers in Immunology

Original Research

Published on 24 Mar 2023

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study

in Intensive Care Medicine and Anesthesiology

Giorgia Montrucchio
Gabriele Sales
Eleonora Balzani
Davide Lombardo
Alice Giaccone
Giulia Cantù
Giulia D'Antonio
Francesca Rumbolo
Silvia Corcione
Umberto Simonetti

Frontiers in Medicine

doi 10.3389/fmed.2023.1122367

5,184 views
10 citations

Original Research

Published on 21 Feb 2020

Classical and Delayed Orthostatic Hypotension in Patients With Unexplained Syncope and Severe Orthostatic Intolerance

in Cardiac Rhythmology

Parisa Torabi
Fabrizio Ricci
Viktor Hamrefors
Richard Sutton
Artur Fedorowski

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.00021

15,631 views
40 citations

Original Research

Published on 02 Jul 2019

Cardiovascular Biomarkers in Amniotic Fluid, Umbilical Arterial Blood, Umbilical Venous Blood, and Maternal Blood at Delivery, and Their Reference Values for Full-Term, Singleton, Cesarean Deliveries

in Neonatology

Martin E. Blohm
Florian Arndt
Glenn M. Fröschle
Nora Langenbach
Jan Sandig
Eik Vettorazzi
Thomas S. Mir
Kurt Hecher
Jochen Weil
Rainer Kozlik-Feldmann

Frontiers in Pediatrics

doi 10.3389/fped.2019.00271

4,783 views
18 citations

Articles

Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist

Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The “PINK-CO” Observational Study

Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination in vulnerable groups: monitoring cardiovascular safety of COVID-19 vaccination

Regulation of MRGPRX2-mediated Mast Cell Function by Competence-stimulating Peptide 1 (CSP-1) and Pro-adrenomedullin Peptide (PAMP-12)

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study

Classical and Delayed Orthostatic Hypotension in Patients With Unexplained Syncope and Severe Orthostatic Intolerance

Cardiovascular Biomarkers in Amniotic Fluid, Umbilical Arterial Blood, Umbilical Venous Blood, and Maternal Blood at Delivery, and Their Reference Values for Full-Term, Singleton, Cesarean Deliveries